American Trust’s Medpace MEDP Stock Holding History

American Trust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-422	Closed	-$203K	–	349
2026 Q1	$203K	Buy	+422	New	+$216K	0.02%	301
2024 Q2	–	Sell	-580	Closed	-$234K	–	284
2024 Q1	$234K	Buy	+580	New	+$204K	0.02%	238

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

American Trust's MEDP Position: Q2 2026 in Review

American Trust sold out of Medpace (MEDP) in Q2 2026, closing a stake of 422 shares — an estimated $203K sold.

American Trust first reported a position in MEDP in Q1 2024 and held it in 2 quarters. The position peaked at $234K in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

American Trust reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
American Trust sold 422 Medpace shares in Q2 2026, an estimated $203K.
American Trust first reported a position in Medpace in Q1 2024 and held it in 2 quarters.
American Trust's Medpace position peaked at $234K in Q1 2024.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.